Imaging features of the evolving patterns of metastatic prostate cancer-Reference-Cited by-同舟云学术

Imaging features of the evolving patterns of metastatic prostate cancer

Published:2022-02 Issue:2 Volume:77 Page:88-95
ISSN:0009-9260
Container-title:Clinical Radiology
language:en
Short-container-title:Clinical Radiology

Author:

Curcean A.,Curcean S.,Rescigno P.,Dafydd D. ap,Tree A.,Reid A.,Koh D.-M.,Sohaib A.,Tunariu N.,Shur J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference47 articles.

1. Cancer incidence and mortality projections in the UK until 2035;Smittenaar;Br J Cancer,2016

2. Cancer Research UK. Prostate cancer incidence statistics. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence (accessed 26th August 2021).

3. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

4. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy;Yossepowitch;Eur Urol,2008

5. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial;Parker;Lancet,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate Cancer;Cancers;2024-07-13

2. Imaging biomarkers between primary and metastatic tumors revealed by total-body positron emission tomography/computed tomography-based radiomics: a case series;Quantitative Imaging in Medicine and Surgery;2024-06

3. Mucinous Adenocarcinoma of the Prostate With Normal Prostate-Specific Antigen Levels, Pulmonary Metastasis, and the Absence of Nodal Disease: A Case Report;Cureus;2024-03-20

4. Multifunctional nano-system for multi-mode targeted imaging and enhanced photothermal therapy of metastatic prostate cancer;Acta Biomaterialia;2023-08

5. Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer;Pharmaceutics;2023-05-30